Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial

Table 1

Characteristics of the trial patients at baseline.

Demographics	Study group ()	Control group ()	value
Age (years)	64.53 ± 14.89	69.03 ± 12.62	0.189
Weight (kg)	53.90 ± 6.60	53.08 ± 8.75	0.675
Sex (male : female)	28 : 12	28 : 17	0.450
APCAHE II	29.67 ± 7.68	30.39 ± 7.10	0.693
SOFA (sepsis-related organization failure assessment)	12.93 ± 2.46	11.71 ± 2.85	0.190
Comorbidities
Severe pneumonia	15	13	0.399
Peritonitis	6	11	0.277
Acute exacerbation of chronic obstructive pulmonary disease	10	13	0.549
Severe acute pancreatitis	4	1	0.165
Biliary tract infection	1	3	0.327
Urinary system infection	2	2	1.000
Fracture with infection	1	0	0.488
Multiple organ dysfunction syndrome	1	1	0.741
Burn	0	1	0.512